RSS-Feed abonnieren
DOI: 10.1055/s-2007-966432
© Georg Thieme Verlag KG Stuttgart · New York
Endoscopic treatment combined with laparoscopic sentinel node mapping for superficial gastrointestinal cancers
Publikationsverlauf
Publikationsdatum:
22. Mai 2007 (online)
Endoscopic mucosal resection (EMR) has been established as a minimally invasive treatment for mucosal gastrointestinal cancer with no risk of lymph node metastasis. Recent advances in endoscopic technologies and devices, including the development of endoscopic submucosal dissection (ESD), have improved local control of superficial gastrointestinal cancer. Novel technologies in endoscopic treatments allow us to resect wider and deeper gastrointestinal cancer lesions. A current major limitation of EMR/ESD is the risk of micrometastasis in regional lymph nodes. To resolve this issue, attention has been focused on the concept of sentinel nodes. The first possible sites of metastasis along the lymphatic drainage route from the primary lesion are known as sentinel nodes. In the past 5 years, a number of single-center studies have been published that support the validity of the sentinel node concept for gastrointestinal cancers. The combination of EMR/ESD and laparoscopic/thoracoscopic sentinel node mapping seems to be a breakthrough that can extend the indication for the endoscopic treatment of gastrointestinal cancers with a potential risk of lymph node metastasis. Although there are several technical obstacles to overcome, this strategy has great potential in the near future as a novel minimally invasive treatment for superficial gastrointestinal cancers.
References
- 1 Hiki Y, Shimao H, Mieno H. et al . Modified treatment of early gastric cancer: evaluation of endoscopic treatment of early gastric cancers with respect to treatment indication groups. World J Surg. 1995; 19 517-522
- 2 Imaeda H, Iwao Y, Ogata H. et al .A new technique for endoscopic submucosal dissection for early gastric cancer using an external grasping forceps. Endoscopy 2006 PMID: 16 673 308 (Epub)
- 3 Fujihiro M, Yahagi N, Kakushima N. et al . En bloc resection of a large semicircular esophageal cancer by endoscopic submucosal dissection. Surg Laparosc Endosc Percutan Tech. 2006; 16 237-241
- 4 Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol. 2006; 22 561-569
- 5 Morton D L, Wen D R, Wong J H. et al . Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127 392-399
- 6 Kitagawa Y, Fujii H, Mukai M. et al . The role of sentinel lymph nodes in gastrointestinal cancer. Surg Clin N Am. 2000; 80 1799-1809
- 7 Saha S, Seghal R, Patel M. et al . A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg. 2006; 191 305-310
- 8 Bilchik A J, DiNome M, Saha S. et al . Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg. 2006; 141 527-533
- 9 Hiratsuka M, Miyashiro I, Ishikawa O. et al . Application of sentinel node biopsy to gastric cancer surgery. Surgery. 2001; 129 335-340
- 10 Yasuda S, Shimada H, Ogoshi K. et al . Preliminary study for sentinel lymph node identification with Tc-99 m tin colloid in patients with esophageal or gastric cancer. Tokai J Exp Clin Med. 2001; 26 15-18
- 11 Ichikura T, Morita D, Uchida T. et al . Sentinel node concept in gastric carcinoma. World J Surg. 2002; 26 318-322
- 12 Kitagawa Y, Fujii H, Mukai M. et al . Radio-guided sentinel node detection for gastric cancer. Br J Surg. 2002; 89 604-608
- 13 Carlini M, Carboni F, Petric M. et al . Sentinel node in gastric cancer surgery. J Exp Clin Cancer Res. 2002; 21 469-473
- 14 Hayashi H, Ochiai T, Mori M. et al . Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg. 2003; 196 68-74
- 15 Miwa K, Kinami S, Taniguchi K. et al . Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg. 2003; 90 178-182
- 16 Gretschel S, Bembenek A, Ulmer C h. et al . Lymphatic mapping and sentinel lymph node biopsy in gastric cancer. Chirurg. 2003; 74 132-138
- 17 Yasuda S, Shimada H, Chino O. et al . Sentinel lymph node detection with Tc-99 m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol. 2003; 33 68-72
- 18 Tonouchi H, Mohri Y, Tanaka K. et al . Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig Surg. 2003; 20 421-427
- 19 Simsa J, Hoch J, Leffler J. et al . Sentinel node biopsy in gastric cancer: preliminary results. Acta Chir Belg. 2003; 103 270-273
- 20 Ryu K W, Lee J H, Kim H S. et al . Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer. Eur J Surg Oncol. 2003; 29 895-899
- 21 Song X, Wang L, Chen W. et al . Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg. 2004; 187 270-273
- 22 Kim M C, Jung G J, Lee J H. et al . Lymph node biopsy with 99mTc tin colloid in patients with gastric carcinoma. Hepatogastroenterology. 2003; 50 (Suppl 2) ccxiv-ccxv
- 23 Nimura H, Narimiya N, Mitsumori N. et al . Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer. Br J Surg. 2004; 91 575-579
- 24 Karube T, Ochiai T, Shimada H. et al . Detection of sentinel lymph nodes in gastric cancers based on immunohistochemical analysis of micrometastases. J Surg Oncol. 2004; 87 32-38
- 25 Kim M C, Kim H H, Jung G J. et al . Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg. 2004; 239 383-387
- 26 Osaka H, Yashiro M, Sawada T. et al . Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer?. Clin Cancer Res. 2004; 10 6912-6918
- 27 Uenosono Y, Natsugoe S, Ehi K. et al . Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg. 2005; 92 886-889
- 28 Zulfikaroglu B, Koc M, Ozmen M M. et al . Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005; 138 899-904
- 29 Park D J, Lee H J, Lee H S. et al . Sentinel node biopsy for cT1 and cT2a gastric cancer. Eur J Surg Oncol. 2006; 32 48-54
- 30 Ishizaki M, Kurita A, Kubo Y. et al . Evaluation of sentinel node identification with isosulfan blue in gastric cancer. Eur J Surg Oncol. 2006; 32 191-196
- 31 Rabin I, Chikmen B, Halpern Z. et al . Sentinel node mapping for gastric cancer. Isr Med Assoc J. 2006; 8 40-43
- 32 Mochiki E, Kuwano H, Kamiyama Y. et al . Sentinel lymph node mapping with technetium-99 m colloidal rhenium sulfide in patients with gastric carcinoma. Am J Surg. 2006; 191 465-469
- 33 Lee J H, Ryu K W, Kim C G. et al . Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol. 2006; 13 1168-74
- 34 Rino Y, Takanashi Y, Harada H. et al .Technique and assessment of sentinel lymph node biopsy usefulness in laparoscopy-assisted distal gastrectomy. Surg Endosc 2006 Oct 5 [Epub ahead of print]
- 35 Heuts E M, vanderEnt F W, Kengen R A. et al . Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol. 2006; 32 278-281
- 36 Natsugoe S, Okumura H, Matsumoto M. et al . Individualization of lymphadenectomy in superficial esophageal squamous cell cancer. Esophagus. 2006; 3 41-45
- 37 Kitagawa Y, Fujii H, Kumai K. et al . Recent advances in sentinel node navigation for gastric cancer - A paradigm shift of surgical management. J Surg Oncol. 2005; 90 147-151
- 38 Kitagawa Y, Kitajima M. Diagnostic validity of radio-guided sentinel node mapping for gastric cancer - a review of current status and future direction. Surg Technol Int. 2006; 15 32-36
- 39 Kitagawa Y, Kitajima M. Laparoscopic sentinel lymph node mapping for early gastric cancer. World J Surg. 2005; 29 416-417
- 40 Matsuda J, Kitagawa Y, Fujii H. et al . Significance of metastasis detected by molecular techniques in sentinel nodes of patients with gastrointestinal cancer. Ann Surg Oncol. 2004; 11 250S-254S
Y. Kitagawa, MD, PhD
Department of Surgery
Keio University School of Medicine
35 Shinanomachi, Shinjuku-ku
Tokyo, 160-8582
Japan
Fax: +81-3-33554707
eMail: kitagawa@sc.itc.keio.ac.jp